Area of research
Genetics · Reproductive Medicine
Research interest
Research interests include BRCA gene mutations in cancer, Ovarian cancer diagnosis and treatment, Genetic factors in colorectal cancer, and Genetic Associations and Epidemiology.
Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i> -deficient tubo-ovarian high-grade serous carcinoma
MRI Surveillance and Breast Cancer Mortality in Women With <i>BRCA1</i> and <i>BRCA2</i> Sequence Variations
Bilateral Oophorectomy and All-Cause Mortality in Women With <i>BRCA1</i> and <i>BRCA2</i> Sequence Variations
Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
Concurrent RB1 loss and <i>BRCA</i> -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
Data from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
Validated biomarker assays confirm that <scp>ARID1A</scp> loss is confounded with <scp>MMR</scp> deficiency, <scp> CD8 <sup>+</sup> TIL </scp> infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma
Prostate cancer risk stratification improved across multiple ancestries with new polygenic hazard score
An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer
Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status
A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data
The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor
The effect of sample size on polygenic hazard models for prostate cancer
Additional SNPs improve the performance of a polygenic hazard score for prostate cancer
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
Shared heritability and functional enrichment across six solid cancers